Should radical nephrectomy be performed in the face of surgically incurable disease?

Curr Opin Urol. 2000 Sep;10(5):429-34. doi: 10.1097/00042307-200009000-00011.

Abstract

The role of cytoreductive nephrectomy in the management of metastatic renal cancer remains controversial. Recent trials, like SWOG 8949 have suggested the usefulness of this approach at least in selected patients with good performance status and other favorable indicators. The timing of cytoreductive nephrectomy has also been controversial and remains so to this time.

Publication types

  • Review

MeSH terms

  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / surgery*
  • Humans
  • Immunotherapy
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery*
  • Neoplasm Metastasis
  • Nephrectomy*
  • Prognosis
  • Time Factors